* Pharmaceutical method patents have been impacted, but to a much lesser degree
[[Media:Dolcera.ppt|Click here ]]to download the Dolcera presentation at the PIUG 2009 Annual Conference
=='''What is In Re Bilski?'''==
In re Bilski, 545 F.3d 943, 88 U.S.P.Q.2d 1385 (Fed. Cir. 2008), is an en banc decision of the United States Court of Appeals for the Federal Circuit (CAFC) on the patenting of method claims, particularly business methods.
=='''The Verdict'''==
The court affirmed the rejection of the patent claims involving a method of hedging risks in commodities trading. The court also reiterated the machine-or-transformation test as the[1] applicable test for patent-eligible subject matter, and stated that the test in State Street Bank v. Signature Financial Group should no longer be relied upon.
== Dolcera analysis raw data ==
* [[In re Bilski 35 USC ยง 101 Rejections - Patent Application Analysis]]
==Contact Dolcera==